Yearly zoledronic acid in postmenopausal osteoporosis - Reply

被引:0
|
作者
Black, Dennis [1 ]
Eriksen, Erik
Sellmeyer, Deborah
机构
[1] Univ Calif San Francisco, San Francisco, CA 94107 USA
[2] Novartis Pharma, CH-4002 Basel, Switzerland
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 357卷 / 07期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:714 / 715
页数:2
相关论文
共 50 条
  • [1] Yearly zoledronic acid in postmenopausal osteoporosis
    Karam, Roger
    Camm, John
    McClung, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (07): : 712 - 713
  • [2] Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
    Black, Dennis M.
    Delmas, Pierre D.
    Eastell, Richard
    Reid, Ian R.
    Boonen, Steven
    Cauley, Jane A.
    Cosman, Felicia
    Lakatos, Peter
    Leung, Ping Chung
    Man, Zulema
    Mautalen, Carlos
    Mesenbrink, Peter
    Hu, Huilin
    Caminis, John
    Tong, Karen
    Rosario-Jansen, Theresa
    Krasnow, Joel
    Hue, Trisha F.
    Sellmeyer, Deborah
    Eriksen, Erik Fink
    Cummings, Steven R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18): : 1809 - 1822
  • [3] Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis
    Woodis, C. Brock
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (7-8) : 1085 - 1089
  • [4] Is yearly intravenous zoledronic acid comparable to weekly oral alendronate for postmenopausal osteoporosis?
    Brandi, Maria Luisa
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (01): : 20 - 21
  • [5] Treatment of postmenopausal osteoporosis, patient perspectives - focus on once yearly zoledronic acid
    Carmona, Raj
    Adachi, Rick
    PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 189 - 193
  • [6] Is yearly intravenous zoledronic acid comparable to weekly oral alendronate for postmenopausal osteoporosis?
    Maria Luisa Brandi
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 20 - 21
  • [8] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis
    Eastell, R.
    Black, D. M.
    Cauley, J. A.
    Cosman, F.
    Cummings, S. R.
    Delmas, P. D.
    Eriksen, E. F.
    Fraser, W. D.
    Hue, T.
    Lakatos, P.
    Leung, P. C.
    Man, Z.
    McLellan, A. R.
    Mesenbrink, P.
    Reid, D. M.
    Reid, I. R.
    Boonen, S. R.
    RHEUMATOLOGY, 2007, 46 : I4 - I4
  • [9] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis
    Black, D.
    Delmas, P. D.
    Eastell, R.
    Reid, I.
    Boonen, S. R.
    Boonens, S. R.
    Cauley, J. A.
    Cosman, F.
    Lakatoss, P.
    Leung, P. C.
    Man, Z.
    Eriksen, E. F.
    Mesenbrink, P.
    Cummings, T. H. S.
    BONE, 2007, 40 (06) : S158 - S158
  • [10] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis
    Black, D.
    Detmas, P. D.
    Eastell, R.
    Reid, I.
    Boonen, S.
    Cauley, J. A.
    Lakatos, P.
    Leung, P. C.
    Man, Z.
    Eriksen, E. F.
    Mesenbrink, P.
    Hue, T.
    Langdahl, B.
    Cummings, S.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S45 - S46